Omnicell, Inc. (OMCL)
Automate Your Wheel Strategy on OMCL
With Tiblio's Option Bot, you can configure your own wheel strategy including OMCL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol OMCL
- Rev/Share 24.3745
- Book/Share 26.9787
- PB 1.1442
- Debt/Equity 0.2977
- CurrentRatio 1.3821
- ROIC 0.0043
- MktCap 1446061932.0
- FreeCF/Share 2.5013
- PFCF 12.4073
- PE 67.9012
- Debt/Assets 0.174
- DivYield 0
- ROE 0.0172
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | OMCL | Wells Fargo | Equal Weight | Overweight | -- | $35 | May 14, 2025 |
News
Is it Apt to Retain Omnicell Stock in Your Portfolio Now?
Published: June 06, 2025 by: Zacks Investment Research
Sentiment: Negative
OMCL stays on investors' radar due to its strong 2025 growth targets with automation and tech services, but faces margin risks from macro and competitive headwinds.
Read More
Omnicell (OMCL) Up 27% Since Last Earnings Report: Can It Continue?
Published: June 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock?
Read More
Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program
Published: May 22, 2025 by: Business Wire
Sentiment: Neutral
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program.
Read More
Omnicell's New Perioperative Clinic Setting Products May Boost Stock
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
OMCL unveils new offerings for the perioperative and clinic setting.
Read More
Omnicell: Facing New Headwinds
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Negative
Omnicell, Inc., a small cap medical technology solutions provider, posted its Q1 results Tuesday. Both top and the bottom-line results beat the consensus. However, thanks to some new headlines and reduced forward guidance, OMCL shares sold off 15% in trading yesterday. A buying opportunity? An analysis around Omnicell follows in the paragraphs below.
Read More
Omnicell, Inc. (OMCL) Q1 2025 Earnings Conference Call Transcript
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Omnicell, Inc. (NASDAQ:OMCL ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Kathleen Nemeth - SVP, IR Randall Lipps - Founder, Chairman, President and CEO Nchacha Etta - EVP and CFO Nnamdi Njoku - COO Conference Call Participants Jessica Datson - Piper Sandler Gene Mannheimer - Freedom Capital Markets Allen Lutz - Bank of America Bill Sutherland - Benchmark Stan Berenshteyn - Wells Fargo Matt Hewitt - Craig-Hallum Capital David Larsen - BTIG Operator Good morning, my name is Carly and I will be your conference operator today. At this time, I would like to …
Read More
Omnicell (OMCL) Beats Q1 Earnings and Revenue Estimates
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Omnicell (OMCL) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.03 per share a year ago.
Read More
Omnicell Announces First Quarter 2025 Results
Published: May 06, 2025 by: Business Wire
Sentiment: Neutral
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces First Quarter 2025 Results.
Read More
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
Published: April 28, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Omnicell (OMCL) is a Strong Value Stock
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
Published: March 25, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Omnicell Gains 41.6% in a Year: What's Driving the Stock?
Published: March 05, 2025 by: Zacks Investment Research
Sentiment: Positive
OMCL's shares rise on the back of its XT Amplify program gaining market acceptance with its offerings. However, the unfavorable macroeconomic scenario is concerning.
Read More
Omnicell (OMCL) Upgraded to Buy: What Does It Mean for the Stock?
Published: February 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Omnicell (OMCL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Omnicell Q4 Earnings: Ignore The Short-Term Noise
Published: February 12, 2025 by: Seeking Alpha
Sentiment: Positive
Omnicell's Q4 2024 earnings showed strong service revenue growth, despite soft overall revenue guidance, highlighting the service business as the key value driver. My updated DCF analysis yields a price target of $64.05, representing a 54% upside, and I raise my rating from buy to strong buy. The service business has grown from 6% to 22% of revenue since 2020, outpacing industry growth and improving margins, indicating long-term value.
Read More
About Omnicell, Inc. (OMCL)
- IPO Date 2001-08-09
- Website https://www.omnicell.com
- Industry Medical - Healthcare Information Services
- CEO Mr. Randall A. Lipps
- Employees 3620